awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33439312-56185C57-B9F1-4995-98FE-6B180A91CF45
Q33439312-56185C57-B9F1-4995-98FE-6B180A91CF45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439312-56185C57-B9F1-4995-98FE-6B180A91CF45
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.
P2860
Q33439312-56185C57-B9F1-4995-98FE-6B180A91CF45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439312-56185C57-B9F1-4995-98FE-6B180A91CF45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2db6e1d26bfc81802f02bb793fff5de87b098e2d
P2860
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo